Illumina, Inc. 0J8Z.L Stock
Illumina, Inc. Price Chart
Illumina, Inc. 0J8Z.L Financial and Trading Overview
Illumina, Inc. stock price | 127.88 USD |
Previous Close | 205.6 USD |
Open | 0 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0 - 0 USD |
52 Week Range | 0 - 247.34 USD |
Volume | 760 USD |
Avg. Volume | 1.91K USD |
Market Cap | 310.35M USD |
Beta (5Y Monthly) | 1.170422 |
PE Ratio (TTM) | 0.4583697 |
EPS (TTM) | 4.56 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0J8Z.L Valuation Measures
Enterprise Value | 34.05B USD |
Trailing P/E | 0.4583697 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.06977292 |
Price/Book (mrq) | 4.928765 |
Enterprise Value/Revenue | 7.655 |
Enterprise Value/EBITDA | 87.532 |
Trading Information
Illumina, Inc. Stock Price History
Beta (5Y Monthly) | 1.170422 |
52-Week Change | 10.71% |
S&P500 52-Week Change | 20.43% |
52 Week High | 247.34 USD |
52 Week Low | 0 USD |
50-Day Moving Average | 210.1 USD |
200-Day Moving Average | 209.43 USD |
0J8Z.L Share Statistics
Avg. Volume (3 month) | 1.91K USD |
Avg. Daily Volume (10-Days) | 799 USD |
Shares Outstanding | 147M |
Float | 157.75M |
Short Ratio | N/A |
% Held by Insiders | 0.28% |
% Held by Institutions | 93.54% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | January 1, 2023 |
Most Recent Quarter (mrq) | April 2, 2023 |
Next Fiscal Year End | January 1, 2024 |
Profitability
Profit Margin | -100.87% |
Operating Margin (ttm) | -0.47% |
Gross Margin | 67.28% |
EBITDA Margin | 8.74% |
Management Effectiveness
Return on Assets (ttm) | -0.097% |
Return on Equity (ttm) | -51.022% |
Income Statement
Revenue (ttm) | 4.45B USD |
Revenue Per Share (ttm) | 28.29 USD |
Quarterly Revenue Growth (yoy) | -11.099% |
Gross Profit (ttm) | 3.15B USD |
EBITDA | 389M USD |
Net Income Avi to Common (ttm) | -4487000064 USD |
Diluted EPS (ttm) | 4.555 |
Quarterly Earnings Growth (yoy) | -96.50% |
Balance Sheet
Total Cash (mrq) | 1.52B USD |
Total Cash Per Share (mrq) | 9.6 USD |
Total Debt (mrq) | 3.06B USD |
Total Debt/Equity (mrq) | 45.75 USD |
Current Ratio (mrq) | 1.422 |
Book Value Per Share (mrq) | 42.361 |
Cash Flow Statement
Operating Cash Flow (ttm) | 230M USD |
Levered Free Cash Flow (ttm) | 448.88M USD |
Profile of Illumina, Inc.
Country | United Kingdom |
State | CA |
City | San Diego |
Address | 5200 Illumina Way |
ZIP | 92122 |
Phone | 858 202 4500 |
Website | https://www.illumina.com |
Industry | |
Sector(s) | |
Full Time Employees | 11500 |
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Q&A For Illumina, Inc. Stock
What is a current 0J8Z.L stock price?
Illumina, Inc. 0J8Z.L stock price today per share is 127.88 USD.
How to purchase Illumina, Inc. stock?
You can buy 0J8Z.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Illumina, Inc.?
The stock symbol or ticker of Illumina, Inc. is 0J8Z.L.
How many shares does Illumina, Inc. have in circulation?
The max supply of Illumina, Inc. shares is 1.49M.
What is Illumina, Inc. Price to Earnings Ratio (PE Ratio)?
Illumina, Inc. PE Ratio is 0.28074646 now.
What was Illumina, Inc. earnings per share over the trailing 12 months (TTM)?
Illumina, Inc. EPS is 4.56 USD over the trailing 12 months.